Trials / Unknown
UnknownNCT03775733
Efficacy and Safety of Hydrolysed Red Ginseng Extract on Improvement of Hyperglycemia
A 12 Weeks, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate The Efficacy and Safety of Hydrolysed Red Ginseng Extract on Improvement of Hyperglycemia
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Chonbuk National University Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
This study was conducted to investigate the effects of daily supplementation of hydrolysed red ginseng extract on improvement of Hyperglycemia.
Detailed description
This study was a 12 weeks, randomized, double-blind, placebo-controlled human trial. Twenty subjects were randomly divided into Hydrolysed Red Ginseng extract or a placebo group. Fasting and postprandial glucose profiles during oral glucose tolerance test (OGTT) were assessed before and after the intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Hydrolysed Red Ginseng Extract | Hydrolysed Red Ginseng Extract 2.4g/day for 12 weeks. |
| DIETARY_SUPPLEMENT | Placebo | Placebo for 12 weeks. |
Timeline
- Start date
- 2018-09-07
- Primary completion
- 2020-12-30
- Completion
- 2020-12-31
- First posted
- 2018-12-14
- Last updated
- 2020-05-08
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03775733. Inclusion in this directory is not an endorsement.